Doximity vs Goodrx Holdings
Goodrx Holdings is the larger business, with $797m of revenue in fiscal 2025 against $645m for Doximity (1.2 times as much). Doximity grew faster (13.1% against 0.6%). Doximity kept more of each dollar of sales as profit: a net margin of 30.4% against 3.8%. Doximity carries less debt relative to equity (0.0% against 80.3%).
| Latest fiscal year | DoximityDOCS, 2026 | Goodrx HoldingsGDRX, 2025 |
|---|---|---|
| Revenue | $645m | $797m |
| Revenue growth | 13.1% | 0.6% |
| Net income | $196m | $30.4m |
| Operating margin | 33.3% | 11.0% |
| Net margin | 30.4% | 3.8% |
| Return on equity | 19.3% | 4.5% |
| Free cash flow | $326m | $164m |
| Cash | $219m | $262m |
| Total debt | $0 | $495m |
| Debt to equity | 0.0% | 80.3% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $432m | $216m |
| Employees | 880 | 697 |
| Market value | $5.91bn | $1.24bn |
| Price vs our value range | Within our value range | Within our value range |
| Moat score | 75 (Strong) | 28 (Weak) |
| Insider trades, 12 months | 0 buys, 21 sales | 0 buys, 14 sales |